Cost-Effectiveness Analysis of Rifaximin-Î‘ Administration for the Reduction of the Overt Hepatic Encephalopathy Episodes in Recurrence in France

Effectiveness Analysis ◽

Overt Hepatic Encephalopathy

Faculty Opinions recommendation of Cost-effectiveness analysis of rifaximin-α administration for the reduction of episodes of overt hepatic encephalopathy in recurrence compared with standard treatment in France.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726613176.793535964 ◽

2017 ◽

Author(s):

Sharon DeMorrow

Keyword(s):

Cost Effectiveness ◽

Hepatic Encephalopathy ◽

Standard Treatment ◽

Effectiveness Analysis ◽

Overt Hepatic Encephalopathy

Cost-effectiveness analysis of rifaximin-α administration for the reduction of episodes of overt hepatic encephalopathy in recurrence compared with standard treatment in France

Therapeutic Advances in Gastroenterology ◽

10.1177/1756283x16644249 ◽

2016 ◽

Vol 9 (4) ◽

pp. 473-482 ◽

Cited By ~ 7

Author(s):

Anastasiia Kabeshova ◽

Soumaia Ben Hariz ◽

Elyonore Tsakeu ◽

Robert Benamouzig ◽

Robert Launois

Keyword(s):

Cost Effectiveness ◽

Hepatic Encephalopathy ◽

Standard Treatment ◽

Effectiveness Analysis ◽

Overt Hepatic Encephalopathy

Faculty Opinions recommendation of Diagnosis and treatment of minimal hepatic encephalopathy to prevent motor vehicle accidents: a cost-effectiveness analysis.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717548013.793003015 ◽

2012 ◽

Author(s):

Stephen Stewart ◽

Zita Galvin

Keyword(s):

Cost Effectiveness ◽

Hepatic Encephalopathy ◽

Motor Vehicle ◽

Minimal Hepatic Encephalopathy ◽

Motor Vehicle Accidents ◽

Diagnosis And Treatment ◽

Vehicle Accidents ◽

Diagnosis and treatment of minimal hepatic encephalopathy to prevent motor vehicle accidents: A cost-effectiveness analysis

Hepatology ◽

10.1002/hep.25507 ◽

2012 ◽

Vol 55 (4) ◽

pp. 1164-1171 ◽

Cited By ~ 80

Author(s):

Jasmohan S. Bajaj ◽

Steven D. Pinkerton ◽

Arun J. Sanyal ◽

Douglas M. Heuman

Keyword(s):

Cost Effectiveness ◽

Hepatic Encephalopathy ◽

Motor Vehicle ◽

Minimal Hepatic Encephalopathy ◽

Motor Vehicle Accidents ◽

Diagnosis And Treatment ◽

Vehicle Accidents ◽

PGI23 COST EFFECTIVENESS ANALYSIS OF RIFAXIMIN FOR THE TREATMENT OF ACUTE HEPATIC ENCEPHALOPATHY

Value in Health ◽

10.1016/s1098-3015(10)72341-x ◽

2010 ◽

Vol 13 (3) ◽

pp. A73

Author(s):

R Rivas ◽

O Cerezo ◽

L Zapata

Keyword(s):

Cost Effectiveness ◽

Hepatic Encephalopathy ◽

Effectiveness Analysis ◽

Acute Hepatic Encephalopathy

Cost-effectiveness analysis of serum vancomycin concentration monitoring in patients with hematologic malignancies

Clinical Pharmacology & Therapeutics ◽

10.1016/s0009-9236(96)90060-0 ◽

1996 ◽

Vol 60 (3) ◽

pp. 332-340 ◽

Cited By ~ 57

Author(s):

M DEGATTA ◽

M CALVO ◽

J HERNANDEZ ◽

D CABALLERO ◽

J SANMIGUEL ◽

...

Keyword(s):

Cost Effectiveness ◽

Hematologic Malignancies ◽

Vancomycin Concentration ◽

Effectiveness Analysis ◽

Serum Vancomycin

Timing of prophylactic surgery for diverticulitis: A cost-effectiveness analysis

Gastroenterology ◽

10.1016/s0016-5085(01)82026-6 ◽

2001 ◽

Vol 120 (5) ◽

pp. A408-A408

Author(s):

R RICHARDS ◽

J HAMMITT

Keyword(s):

Cost Effectiveness ◽

Prophylactic Surgery ◽

Cost-Effectiveness Analysis Methods

PsycEXTRA Dataset ◽

10.1037/e549142012-001 ◽

2002 ◽

Author(s):

Eugene Laska ◽

Morris Meisner ◽

Carole Siegel ◽

Joseph Wanderling

Keyword(s):

Cost Effectiveness ◽

Effectiveness Analysis ◽

Analysis Methods

Cost-Effectiveness Analysis of Computerized Tomography in the Routine Follow-Up of Patients After Primary Treatment for Hodgkin's Disease

Yearbook of Diagnostic Radiology ◽

10.1016/s0098-1672(08)70141-3 ◽

2007 ◽

Vol 2007 ◽

pp. 203-204

Author(s):

A.D. Elster

Keyword(s):

Cost Effectiveness ◽

Computerized Tomography ◽

Hodgkin's Disease ◽

Hodgkin’S Disease ◽

Primary Treatment ◽